CONJUNCTIVITIS INFECTION: A BRIEF REVIEW ON ITS CLASSIFICATION, ETIOLOGY AND THERAPEUTIC INTERVENTIONS

M ZULFIQAR; S RAFIQUE; A HABIB; A QADER; A ASGHAR; R RIAZ

doi:10.54112/bcsrj.v2024i1.780

Authors

M ZULFIQAR College of Pharmacy, Lyallpur Institute of Advanced Studies (LIAS), Faisalabad, Pakistan
S RAFIQUE Department of Pharmacy, The University of Faisalabad, Faisalabad, Pakistan
A HABIB Medina College of Pharmacy, The University of Faisalabad, Faisalabad, Pakistan
A QADER Department of Pharmaceutical Chemistry Government College University Faisalabad, Pakistan/ Primary and Secondary Health Care Department, Government of Punjab, Pakistan
A ASGHAR Riphah Institute of Pharmaceutical Sciences, Riphah International University Faisalabad Campus, Pakistan
R RIAZ Riphah Institute of Pharmaceutical Sciences, Riphah International University Faisalabad Campus, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.780

Keywords:

Antibiotics, Conjunctivitis, Categories, Treatment

Abstract

Conjunctivitis is a common inflammatory disease in humans, and it has different types of categories, such as acute, chronic, infectious, and noninfectious. Conjunctivitis may break as an epidemic in different areas of the world. It causes discomfort in the eyes. Some signs and symptoms like redness of the eye, eye discharge, grittiness of the eyes, and lashes sticking together may appear. Based on etiologic agents, conjunctivitis is classified as viral conjunctivitis, bacterial conjunctivitis, allergic conjunctivitis, follicular conjunctivitis, and neonatal conjunctivitis. It may be due to contact with people having eye infections. Many strains of bacteria, viruses, and allergens cause different types of conjunctivitis. Many treatment strategies are applied to treat various kinds of conjunctivitis worldwide. Usually, antibiotics are used for the treatment of conjunctivitis, such as ophthalmic ointments erythromycin, chloramphenicol, and fusidic acid treatment. As a home remedy, many people wash their eyes with normal saline and water to reduce the duration of eye diseases.

Downloads

Download data is not yet available.

References

BenEzra D. Current practice: diagnosis and treatment in primary healthcare. Allergy. 1995;50(21 Suppl):30-3

Shekhawat NS, Shtein RM, Blachley TS, Stein JD. Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network. Ophthalmology 2017;124:1099–1107.

pflipsen m, massaquoi m, wolf s. Evaluation of the painful eye. I am a fam physician. 2016;93:991–998

BenEzra D. Current practice: diagnosis and treatment in primary healthcare. Allergy. 1995;50(21 Suppl):30-3.

de Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L, de Baulny HO, Pintos-Morell G, Spiekerkötter U. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis. 2013 Jan 11;8:8.

Sati A, Sangwan VS, Basu S. Porphyria: varied ocular manifestations and management. BMJ Case Rep. 2013 May 22;2013.

Sheikh A, Hurwitz B Topical antibiotics for acute bacterial conjunctivitis: a systematic review.Br J Gen Pract2001; 51:473–7.

Everitt H, Little P.How do GPs diagnose and manage acute infective conjunctivitis? A GP survey.Fam Pract2002; 19:658–60.

American Academy of Ophthalmology Cornea/External DiseasePreferred Practice Pattern Panel. Conjunctivitis Preferred Practice Pattern®. San Francisco, CA: American Academy of Ophthalmology; 2018. Available from https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018. Accessed November 26, 2018.

Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–1729. doi:10.1001/jama.2013.28031

Patel N, Venkateswaran N, Wang Z, Galor A. Ocular involvement in atopic disease: a review. Curr Opin Ophthalmol. 2018;29:576–581.

Butrus S, Portela R. Ocular allergy: diagnosis and treatment. Ophthalmol Clin North Am. 2005;18:485–492.

Bielory L, Frohman L: Allergic and immunologic disorders of the eye. J Allergy Clin Immunol. 1992, 86: 1-20.

Bielory L, Meltzer EO, Nichols KK, Melton R, Thomas RK, Bartlett JD. An algorithm for the management of allergic conjunctivitis. Allergy Asthma Proc. 2013;34(5):408–20

Barney N, Cook E, Stahl J. Allergic and immunologic diseases of the eye. In: Adkinson Jr N, Bochner B, Burks W, Busse W, Holgate S, editors. Middleton’s allergy: principles and practice. 8th ed. Philadelphia: Elsevier Health Sciences; 2013. p. 618–38.

Bielory L. Allergic and immunologic disorders of the eye. Part II: ocular allergy. J Allergy Clin Immunol. 2000;106(6):1019–32.

Cindy Hutnik & Mohammad H Mohammad-Shahi (2010) Bacterial conjunctivitis, Clinical Ophthalmology, 4:, 1451-1457, DOI: 10.2147/OPTH.S10162

Epling J. Bacterial conjunctivitis. BMJ Clin Evid. 2012 Feb 20;2012:0704. PMID: 22348418; PMCID: PMC3635545

Abdulsalam M, Ibrahim M, Asani M O. An overview of neonatal conjuctivitis . Sudan Med Monit 2015;10:91-8

Andrew Zikic, Holger Schünemann, Teodora Wi, Ornella Lincetto, Nathalie Broutet, Nancy Santesso, Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis, Journal of the Pediatric Infectious Diseases Society, Volume 7, Issue 3, September 2018, Pages e107–e115, https://doi.org/10.1093/jpids/piy060

Abdulsalam M, Ibrahim M, Asani M O. An overview of neonatal conjuctivitis . Sudan Med Monit 2015;10:91-8

https://doi.org/10.3389/fmed.2017.00105

Artieda J, Montes M, Vicente D, et al. Outbreak of follicular conjunctivitis caused by adenovirus in a geriatric centre. Enfermedades Infecciosas y Microbiologia Clinica. 2010 Dec;28 (10):690-693. DOI: 10.1016/j.eimc.2010.04.008. PMID: 20952102.

de Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L, de Baulny HO, Pintos-Morell G, Spiekerkötter U. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis. 2013 Jan 11;8:8.

Sati A, Sangwan VS, Basu S. Porphyria: varied ocular manifestations and management. BMJ Case Rep. 2013 May 22;2013.

Iwalokun, B.A., Oluwadun, A., Akinsinde, K.A. et al. Bacteriologic and plasmid analysis of etiologic agents of conjunctivitis in Lagos, Nigeria. J Ophthal Inflamm Infect 1, 95–103 (2011). https://doi.org/10.1007/s12348-011-0024-z

Therapeutics, Pharmacology & Clinical Toxicology, 2010, Vol 14, Issue 2, p103

ZHANG L, ZHAO N, SHA J, et al. Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953–2013. Epidemiology and Infection. 2016;144(8):1661-1672. doi:10.1017/S0950268815003246

Attarha, M. Effect of Brewed Black Tea as Adjust Treatment in Severity of Infants' Conjunctivitis. Pediatr Res 70 (Suppl 5), 427 (2011). https://doi.org/10.1038/pr.2011.652

. Benitez-del-Castillo, J., Verboven, Y., Stroman, D. et al. The Role of Topical Moxifloxacin, a New Antibacterial in Europe, in the Treatment of Bacterial Conjunctivitis. Clin. Drug Investig. 31, 543–557 (2011). https://doi.org/10.2165/11589020-000000000-00000

Palmares J, Delgado L, Cidade M, Quadrado MJ, Filipe HP, Season Study Group. Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life. Eur J Ophthalmol. 2010;20(2):257–64

Emanuel IA, Parker MJ, Traub O. Undertreatment of allergy: exploring the utility of sublingual immunotherapy. Otolaryngol Head Neck Surg. 2009;140 (5):615–21.

Chan LY, Adam RS, Adam DN. Localized topical steroid use and central serous retinopathy. J Dermatolog Treat. 2016;27(5):425–6.

Renfro L, Snow JS. Ocular effects of topical and systemic steroids. Dermatol Clin. 1992;10(3):505–12.

Benitez-del-Castillo, J., Verboven, Y., Stroman, D. et al. The Role of Topical Moxifloxacin, a New Antibacterial in Europe, in the Treatment of Bacterial Conjunctivitis. Clin. Drug Investig. 31, 543–557 (2011). https://doi.org/10.2165/11589020-000000000-00000

Parys, W., Blockhuys, S. & Janssens, M. New trends in the treatment of allergic conjunctivitis. Doc Ophthalmol 82, 353–360 (1992). https://doi.org/10.1007/BF00161023

Skevaki, C.L., Galani, I.E., Pararas, M.V. et al. Treatment of Viral Conjunctivitis with Antiviral Drugs. Drugs 71, 331–347 (2011). https://doi.org/10.2165/11585330-000000000-00000

. Skevaki, C.L., Galani, I.E., Pararas, M.V. et al. Treatment of Viral Conjunctivitis with Antiviral Drugs. Drugs 71, 331–347 (2011). https://doi.org/10.2165/11585330-000000000-00000.

Everitt H, Little P. How do GPs diagnose and manage acute infective conjunctivitis? A GP survey. Fam Pract 2002;19:658–660.

de Laet C, Dionisi-Vici C, Leonard JV, McKiernan P, Mitchell G, Monti L, de Baulny HO, Pintos-Morell G, Spiekerkötter U. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis. 2013 Jan 11;8:8.

American Academy of Ophthalmology Cornea/External DiseasePreferred Practice Pattern Panel. Conjunctivitis Preferred Practice Pattern®. San Francisco, CA: American Academy of Ophthalmology; 2018. Available from https://www.aao.org/preferred-practice-pattern/conjunctivitis-ppp-2018. Accessed November 26, 2018.

Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–1729. doi:10.1001/jama.2013.280318

.Leonardi S, del Giudice Miraglia M, La Rosa M, Bellanti JA: Atopic disease, immune system, and the environment. Allergy Asthma Proc. 2007, 28 (4): 410-417. 10.2500/aap.2007.28.2954.

Hyperosmolar conjunctival provocation for the evaluation of nonspecific hyperreactivity in healthy patients and patients with allergy J Allergy Clin Immunol (2006).

Saleem, A., Davis, M., Rafique, S., Meer, S., Qader, A., & Aslam, M. N. (2023). A Critical Glance to Non-Pharmacological Management of Novel COVID-19 Infection: Non-Pharmacological Management of COVID-19 Infection. Pakistan Journal of Health Sciences, 02-13.